Patient-focused Interactive Decision Support Tool

Share

Program Content

Activities

  • Expert Insights on HER2+ EBC
    Treatment Options From 5 Experts on Neoadjuvant and Adjuvant Therapy for HER2-Positive Early Breast Cancer: An Online Tool
    Tool
    Congratulations: You achieved a completion on 04/09/2022

    Released: March 19, 2019

    Expires: March 17, 2020

Provided by

ProCE Banner

Supporters

Genentech TEXT Only

Partners

GRACE

ProCE Banner